WO2011037415A2 - 부탄올 생성능이 증가된 재조합 미생물 및 이를 이용한 부탄올의 제조방법 - Google Patents
부탄올 생성능이 증가된 재조합 미생물 및 이를 이용한 부탄올의 제조방법 Download PDFInfo
- Publication number
- WO2011037415A2 WO2011037415A2 PCT/KR2010/006511 KR2010006511W WO2011037415A2 WO 2011037415 A2 WO2011037415 A2 WO 2011037415A2 KR 2010006511 W KR2010006511 W KR 2010006511W WO 2011037415 A2 WO2011037415 A2 WO 2011037415A2
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- coa
- butanol
- gene encoding
- gene
- recombinant microorganism
- Prior art date
Links
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 title claims abstract description 210
- 244000005700 microbiome Species 0.000 title claims abstract description 92
- 238000004519 manufacturing process Methods 0.000 title claims abstract description 54
- 238000002360 preparation method Methods 0.000 title abstract description 4
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 144
- ZSLZBFCDCINBPY-ZSJPKINUSA-N acetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 ZSLZBFCDCINBPY-ZSJPKINUSA-N 0.000 claims abstract description 63
- 102000004190 Enzymes Human genes 0.000 claims abstract description 36
- 108090000790 Enzymes Proteins 0.000 claims abstract description 36
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims abstract description 29
- CRFNGMNYKDXRTN-CITAKDKDSA-N butyryl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CCC)O[C@H]1N1C2=NC=NC(N)=C2N=C1 CRFNGMNYKDXRTN-CITAKDKDSA-N 0.000 claims abstract description 28
- 230000006696 biosynthetic metabolic pathway Effects 0.000 claims abstract description 13
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 52
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 claims description 35
- 241000193403 Clostridium Species 0.000 claims description 32
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 claims description 29
- 241000423302 Clostridium acetobutylicum ATCC 824 Species 0.000 claims description 27
- 238000012217 deletion Methods 0.000 claims description 25
- 230000037430 deletion Effects 0.000 claims description 25
- 238000000034 method Methods 0.000 claims description 25
- 108020002663 Aldehyde Dehydrogenase Proteins 0.000 claims description 23
- 102000005369 Aldehyde Dehydrogenase Human genes 0.000 claims description 22
- 102000004357 Transferases Human genes 0.000 claims description 21
- 108090000992 Transferases Proteins 0.000 claims description 21
- 102000007698 Alcohol dehydrogenase Human genes 0.000 claims description 17
- 108010021809 Alcohol dehydrogenase Proteins 0.000 claims description 17
- 241000193401 Clostridium acetobutylicum Species 0.000 claims description 17
- 108700023175 Phosphate acetyltransferases Proteins 0.000 claims description 15
- 101150105921 eutD gene Proteins 0.000 claims description 15
- 108700024126 Butyrate kinases Proteins 0.000 claims description 14
- 108010092060 Acetate kinase Proteins 0.000 claims description 12
- 101100433987 Latilactobacillus sakei subsp. sakei (strain 23K) ackA1 gene Proteins 0.000 claims description 9
- 101150006213 ackA gene Proteins 0.000 claims description 9
- 101000695175 Bacillus subtilis (strain 168) Probable phosphate butyryltransferase Proteins 0.000 claims description 8
- OJFDKHTZOUZBOS-CITAKDKDSA-N acetoacetyl-CoA Chemical compound O[C@@H]1[C@H](OP(O)(O)=O)[C@@H](COP(O)(=O)OP(O)(=O)OCC(C)(C)[C@@H](O)C(=O)NCCC(=O)NCCSC(=O)CC(=O)C)O[C@H]1N1C2=NC=NC(N)=C2N=C1 OJFDKHTZOUZBOS-CITAKDKDSA-N 0.000 claims description 7
- 101710088194 Dehydrogenase Proteins 0.000 claims description 6
- WDJHALXBUFZDSR-UHFFFAOYSA-M acetoacetate Chemical compound CC(=O)CC([O-])=O WDJHALXBUFZDSR-UHFFFAOYSA-M 0.000 claims description 6
- 150000001413 amino acids Chemical class 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 5
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 125000002485 formyl group Chemical class [H]C(*)=O 0.000 claims 2
- QZHUEMFFIHZPTJ-HRXFNJBOSA-N S-[2-[3-[[(2R)-4-[[[(2R,3S,4R,5R)-5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-hydroxyphosphoryl]oxy-2-hydroxy-3,3-dimethylbutanoyl]amino]propanoylamino]ethyl] butanethioate Chemical compound C(CCC)(=O)SCCNC(CCNC([C@@H](C(COP(OP(OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC=2C(N)=NC=NC12)O)OP(=O)(O)O)(=O)O)(=O)O)(C)C)O)=O)=O.C(CCC)(=O)SCCNC(CCNC([C@@H](C(COP(OP(OC[C@@H]1[C@H]([C@H]([C@@H](O1)N1C=NC=2C(N)=NC=NC12)O)OP(=O)(O)O)(=O)O)(=O)O)(C)C)O)=O)=O QZHUEMFFIHZPTJ-HRXFNJBOSA-N 0.000 claims 1
- 230000002503 metabolic effect Effects 0.000 abstract description 5
- 230000037353 metabolic pathway Effects 0.000 abstract description 2
- 239000000446 fuel Substances 0.000 abstract 1
- 239000004434 industrial solvent Substances 0.000 abstract 1
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 51
- 239000013598 vector Substances 0.000 description 31
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 27
- 101150054092 buk gene Proteins 0.000 description 22
- 101150031417 buk1 gene Proteins 0.000 description 19
- 101150108780 pta gene Proteins 0.000 description 15
- 230000037361 pathway Effects 0.000 description 14
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 12
- 238000012224 gene deletion Methods 0.000 description 12
- 150000001299 aldehydes Chemical class 0.000 description 11
- 101150048333 ptb gene Proteins 0.000 description 11
- 101150052992 PTBP1 gene Proteins 0.000 description 10
- 150000007524 organic acids Chemical class 0.000 description 10
- 230000003115 biocidal effect Effects 0.000 description 9
- 239000012634 fragment Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical group CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 8
- 229920001817 Agar Polymers 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 238000000855 fermentation Methods 0.000 description 8
- 230000004151 fermentation Effects 0.000 description 8
- 239000003550 marker Substances 0.000 description 8
- 108091008146 restriction endonucleases Proteins 0.000 description 8
- 108060008225 Thiolase Proteins 0.000 description 7
- 239000002904 solvent Substances 0.000 description 7
- 229960003053 thiamphenicol Drugs 0.000 description 7
- OTVAEFIXJLOWRX-NXEZZACHSA-N thiamphenicol Chemical compound CS(=O)(=O)C1=CC=C([C@@H](O)[C@@H](CO)NC(=O)C(Cl)Cl)C=C1 OTVAEFIXJLOWRX-NXEZZACHSA-N 0.000 description 7
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 6
- 102000001253 Protein Kinase Human genes 0.000 description 6
- 102000002932 Thiolase Human genes 0.000 description 6
- 238000010367 cloning Methods 0.000 description 6
- 229960003276 erythromycin Drugs 0.000 description 6
- 239000008103 glucose Substances 0.000 description 6
- 235000005985 organic acids Nutrition 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 5
- 101100385573 Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) ctfB gene Proteins 0.000 description 5
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 5
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 230000000903 blocking effect Effects 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 5
- 229960005091 chloramphenicol Drugs 0.000 description 5
- WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 description 5
- 230000007850 degeneration Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 230000006801 homologous recombination Effects 0.000 description 5
- 238000002744 homologous recombination Methods 0.000 description 5
- 239000002207 metabolite Substances 0.000 description 5
- 239000013612 plasmid Substances 0.000 description 5
- 239000013605 shuttle vector Substances 0.000 description 5
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 4
- 102100034343 Integrase Human genes 0.000 description 4
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 4
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000010276 construction Methods 0.000 description 4
- 230000006798 recombination Effects 0.000 description 4
- 238000005215 recombination Methods 0.000 description 4
- 238000000926 separation method Methods 0.000 description 4
- 108010051219 Cre recombinase Proteins 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 239000006227 byproduct Substances 0.000 description 3
- 101150060293 ctfB gene Proteins 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000001954 sterilising effect Effects 0.000 description 3
- 238000004659 sterilization and disinfection Methods 0.000 description 3
- ROWKJAVDOGWPAT-UHFFFAOYSA-N Acetoin Chemical compound CC(O)C(C)=O ROWKJAVDOGWPAT-UHFFFAOYSA-N 0.000 description 2
- 241000193171 Clostridium butyricum Species 0.000 description 2
- 238000006873 Coates reaction Methods 0.000 description 2
- 102000003960 Ligases Human genes 0.000 description 2
- 108090000364 Ligases Proteins 0.000 description 2
- 238000012408 PCR amplification Methods 0.000 description 2
- 108010091086 Recombinases Proteins 0.000 description 2
- 102000018120 Recombinases Human genes 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 108091022873 acetoacetate decarboxylase Proteins 0.000 description 2
- 230000003698 anagen phase Effects 0.000 description 2
- 239000002551 biofuel Substances 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 210000000349 chromosome Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 101150036876 cre gene Proteins 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 230000002068 genetic effect Effects 0.000 description 2
- 230000011987 methylation Effects 0.000 description 2
- 238000007069 methylation reaction Methods 0.000 description 2
- 230000035772 mutation Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- -1 phospho Chemical class 0.000 description 2
- 238000000746 purification Methods 0.000 description 2
- 230000010076 replication Effects 0.000 description 2
- 238000012216 screening Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 230000009466 transformation Effects 0.000 description 2
- 239000012137 tryptone Substances 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- 108010013043 Acetylesterase Proteins 0.000 description 1
- 108020005544 Antisense RNA Proteins 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 241000193163 Clostridioides difficile Species 0.000 description 1
- 101100385572 Clostridium acetobutylicum (strain ATCC 824 / DSM 792 / JCM 1419 / LMG 5710 / VKM B-1787) ctfA gene Proteins 0.000 description 1
- 241000193454 Clostridium beijerinckii Species 0.000 description 1
- 241000186570 Clostridium kluyveri Species 0.000 description 1
- 241000193468 Clostridium perfringens Species 0.000 description 1
- 241000429427 Clostridium saccharobutylicum Species 0.000 description 1
- 241001508458 Clostridium saccharoperbutylacetonicum Species 0.000 description 1
- 241000193449 Clostridium tetani Species 0.000 description 1
- 241000193452 Clostridium tyrobutyricum Species 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 108700007698 Genetic Terminator Regions Proteins 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 1
- 230000002053 acidogenic effect Effects 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- UVMPXOYNLLXNTR-UHFFFAOYSA-N butan-1-ol;ethanol;propan-2-one Chemical compound CCO.CC(C)=O.CCCCO UVMPXOYNLLXNTR-UHFFFAOYSA-N 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 210000000078 claw Anatomy 0.000 description 1
- 239000003184 complementary RNA Substances 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 229910001873 dinitrogen Inorganic materials 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 230000034659 glycolysis Effects 0.000 description 1
- GFAZHVHNLUBROE-UHFFFAOYSA-N hydroxymethyl propionaldehyde Natural products CCC(=O)CO GFAZHVHNLUBROE-UHFFFAOYSA-N 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000012966 insertion method Methods 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 238000012269 metabolic engineering Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000018791 negative regulation of catalytic activity Effects 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 235000013348 organic food Nutrition 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 210000003705 ribosome Anatomy 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P7/00—Preparation of oxygen-containing organic compounds
- C12P7/02—Preparation of oxygen-containing organic compounds containing a hydroxy group
- C12P7/04—Preparation of oxygen-containing organic compounds containing a hydroxy group acyclic
- C12P7/16—Butanols
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0006—Oxidoreductases (1.) acting on CH-OH groups as donors (1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/10—Transferases (2.)
- C12N9/1025—Acyltransferases (2.3)
- C12N9/1029—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y101/00—Oxidoreductases acting on the CH-OH group of donors (1.1)
- C12Y101/01—Oxidoreductases acting on the CH-OH group of donors (1.1) with NAD+ or NADP+ as acceptor (1.1.1)
- C12Y101/01001—Alcohol dehydrogenase (1.1.1.1)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01008—Phosphate acetyltransferase (2.3.1.8)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y203/00—Acyltransferases (2.3)
- C12Y203/01—Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
- C12Y203/01019—Phosphate butyryltransferase (2.3.1.19)
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02E—REDUCTION OF GREENHOUSE GAS [GHG] EMISSIONS, RELATED TO ENERGY GENERATION, TRANSMISSION OR DISTRIBUTION
- Y02E50/00—Technologies for the production of fuel of non-fossil origin
- Y02E50/10—Biofuels, e.g. bio-diesel
Definitions
- the present invention relates to a recombinant microorganism having increased butanol producing ability and a method for producing butanol using the same, and more particularly, to a recombinant microorganism having increased butanol producing ability through a metabolic circuit and a method for producing butanol using the same.
- Microorganisms in the genus Clostridium are Gram-positive, fully anaerobic and endogenous spores, most of which are known to produce acetate and butyric acid as fermentation products. Some of these strains cause acetone-butanol-ethanol fermentation (hereinafter referred to as ABE fermentation) to produce acetone, butanol, and ethanol in addition to the organic acid.
- ABE fermentation acetone-butanol-ethanol fermentation
- acetone, butanol and ethanol have a mass ratio of about 3: 6: 1 after fermentation, and a small amount of acetate, butyrate, and acetoin are produced.
- glucose used as a substrate
- the mass yield of butanol is about 20-25%
- the final concentration is known to be about 10 g / L (Lee et al., Biotechnol. Bioeng ., 101 (2): 209-228, 2008).
- the wild-type strain is used for the production of butanol, there is a problem that low yield, productivity, and difficult to separate from other metabolites increase the production cost.
- Acetone is formed by acetoacetyl CoA (CoA transferase) and CoA transferase (CoA transferase) and acetoacetate decarboxylase (acetoacetate decarboxylase). They are expressed by genes ctfAB and adc , respectively. Thus, by deleting one or more of these genes, the proportion of acetone in the solvent can be lowered. Recent reports have shown that the deletion of adc can actually lower the specific weight of acetone (Jiang et al., Metab. Eng ., 11 (4-5): 284-291, 2009).
- WO2008 / 052973 reported strains 'butyrate production pathway blocking + acetate production pathway blocking' and strains 'butyrate production pathway blocking + acetone production pathway blocking + acetate production pathway blocking' and the like. Since it is essential, it could not be confirmed whether butanol production ability was improved by deleting only the acetate production route alone.
- WO2008 / 052973 claims for various combinations of gene deletions based on buk or ptb deletions the examples only show the results of the deletion of known buk genes, and there are no examples of gene deletions of various combinations thereafter. There is no problem.
- the present inventors confirmed that when the gene encoding the enzyme for converting acetyl CoA to acetate in Clostridium microorganism is deleted, butanol production ability is improved by increasing the selectivity and yield of butanol.
- the present invention has been completed.
- the present inventors further produce a butanol producing microorganism having high concentration, high yield, and high selectivity by deleting buk gene and amplifying aldehyde / alcohol dehydrogenase in addition to pta deletion mutant with improved butanol selectivity and yield.
- the high yield, high selectivity of butanol formation ability was confirmed, and the present invention was completed.
- the present inventors additionally delete the bukII gene encoding another butyrate kinase in a mutant strain in which the pta and buk are deleted at the same time and amplified aldehyde / alcohol dehydrogenase, thereby producing a high concentration of almost no organic acid.
- a high yield, high selective butanol producing strain was prepared, the butanol producing ability was confirmed, and the present invention was completed.
- the inventors further deleted the ctfB gene encoding coeitransferase (CoAT) in a mutant strain in which the pta, buk, and bukII were simultaneously deleted and amplified aldehyde / alcohol dehydrogenase, thereby producing little organic acid.
- CoAT coeitransferase
- An object of the present invention is to provide a recombinant microorganism and a method for producing the same, which selectively produces butanol with high efficiency by reducing the production of other by-products.
- Another object of the present invention to provide a method for producing butanol using the recombinant microorganism.
- the present invention is a host microorganism having an acetyl CoA and butyryl CoA biosynthesis pathway, encoding an enzyme for converting acetyl CoA to acetate It provides a method for producing a recombinant microorganism having increased butanol production ability, characterized in that the gene is deleted.
- the present invention also provides for the deletion of a gene encoding an enzyme that converts acetyl CoA to acetate in a host microorganism having a biosynthetic pathway to acetyl CoA and butyryl CoA.
- a recombinant microorganism having increased butanol producing ability which is characterized by the above-mentioned.
- the present invention also relates to a gene encoding phosphotrans-acetylase ( eutD or pta ) or a gene encoding acetate kinase ( askA or ackA ) in a microorganism of the genus Clostridium .
- the present invention provides a recombinant microorganism having increased butanol production ability, which is characterized in that the deletion of.
- the invention also, the butanol productivity increased recombinant microorganism Clostridium acetobutylicum ATCC 824 ⁇ eutD, Clostridium acetobutylicum ATCC 824 ⁇ eutD ⁇ buk PptbAdh, Clostridium acetobutylicum ATCC 824 ⁇ eutD ⁇ buk PthlAdh *, C. actobutylicum ATCC 824 ⁇ eutD ⁇ buk ⁇ bukII PthlAdh * and C. ATCC actobutylicum 824 ⁇ eutD ⁇ buk ⁇ bukII ⁇ ctfB PthlAdh *.
- the present invention also comprises the steps of culturing the recombinant microorganism to produce butanol; And it provides a method for producing butanol comprising the step of recovering butanol from the culture.
- Figure 2 is a genetic map of the gene deletion vector (pCACKO) prepared according to an embodiment of the present invention.
- FIG. 3 is a genetic map of the plasmid pIMP1PbAdhE1 prepared according to one embodiment of the present invention.
- a gene encoding phosphotransacetylase, which is involved in converting acetyl CoA to acetate from the gene of Clostridium acetobutylicum ATCC 824, ( eutD )
- eutD Clostridium acetobutylicum ATCC 824
- the present invention provides a gene encoding an enzyme that converts acetyl CoA to acetate in a host microorganism having an acetyl CoA and butyryl CoA biosynthetic pathway.
- the present invention relates to a method for producing a recombinant microorganism having increased butanol producing ability, and a recombinant microorganism having increased butanol producing ability prepared therefrom.
- the "biosynthetic pathway” is not limited to a pathway for synthesizing a target compound from carbon provided through glycolysis, and a concept encompassing pathways for synthesizing a target compound from specific metabolites in cells.
- “deleted” means that by changing, replacing or deleting some bases of the gene, introducing some bases, or introducing a gene, enzyme or chemical that inhibits the expression or activity of the enzyme,
- the concept encompasses the inhibition of enzyme activity. Therefore, for the method of deleting a specific gene, expression inhibition using antisense RNA known previously, homologous recombination, homologous recombination through expression of various recombinases (rambda recombinase, etc.), specificity using reverse transcriptase and RNA As long as the activity of the specific gene of interest and the enzyme which the gene encodes is inhibited by the method of sequence insertion etc., it is not limited to any specific method.
- acetyl CoA and butyryl CoA biosynthesis pathways not only has inherent in the strain itself but also techniques such as recombination and genome shuffling. It includes all the things which introduced foreign gene.
- the host microorganism having the acetyl CoA and butyryl CoA biosynthesis pathway produces at least one selected from the group consisting of acetone, ethanol, butanol, isopropanol It is done.
- the host microorganism may be derived from the genus Clostridium, but has a gene encoding enzymes involved in the biosynthetic pathway to acetyl CoA and butyryl CoA. It is not limited to one.
- Clostridium acetobutylicum Clostridium beijerinckii , Clostridium saccharobutylicum , Clostridium saccharopfer Clostridium saccharoperbutylacetonicum , Clostridium perfringens , Clostridium tetani , Clostridium difficile , Clostridium butyricum , Clostridium butyricum Examples include Clostridium butylicum , Clostridium kluyveri , Clostridium tyrobutylicum, Clostridium tyrobutyricum, and the like. .
- Clostridium acetobutylicum ATCC824 is illustrated as a host microorganism of the genus Clostridium, but in addition to Clostridium acetobutylicum M5, 1NYG, 4NYG, 5NYG and DG1 (Stim-Herndon, KP et al., Biotechnol / Food Microbiol ., 2:11, 1996) and Clostridium acetobutylicum ATCC 824 Type IV, M3, M5, 2-BB R, 2-BB D, Rif B12, Rif D10, Rif F7, and Claw Stridial acetobutylicum ATCC 860 (Clark, SW et al., Appl. Environ. Microbiol. , 55: 970, 1989) can also be used.
- the enzyme for converting acetyl CoA to acetate is phosphotrans-acetylase or acetate kinase, and the phosphotrans-acetylase
- the gene encoding acetylase) is eutD or pta
- the gene encoding acetate kinase is characterized as askA or ackA .
- the gene deletion method is not particularly limited as long as the activity of the enzyme encoded by the gene of interest is suppressed.
- the homologous recombination method by double crossing inserts an antibiotic resistance gene into a gene fragment having a nucleotide sequence of the target gene to inactivate the action of the target gene fragment, and then inactivates the target gene fragment into the strain.
- the target gene in the chromosome of the microorganism can be inactivated.
- a specific sequence insertion method using reverse transcriptase and RNA finds a reverse transcriptase binding site in a target gene, and then, by RNA and reverse transcriptase complex expressed at an RNA transcription site substituted by a partial sequence adjacent to the binding site. Part of the RNA can be inserted into the gene of interest to inhibit the activity of the enzyme of interest so that the gene of interest.
- a recombinant microorganism having a gene ( eutD ) encoding a phospho trans acetylase was prepared , and the produced recombinant microorganism had an improved butanol generating ability.
- (C) a recombinant microorganism additionally deleted the ctf A or ctfB gene coding for CoA transferase (CoAT) was produced, and the high concentration, high yield, high selective butanol in which the produced recombinant microorganism produces little organic acid. The production capacity was confirmed.
- the method for producing a recombinant microorganism having increased butanol producing ability is eutD ( pta ) and ackA encoding phospho -acetylase and acetate kinase, which convert acetyl-CoA to acetic acid.
- eutD pta
- ackA encoding phospho -acetylase and acetate kinase
- a gene encoding an enzyme to make and (b) a gene encoding phosphotrans-butyrylase that converts butyryl-CoA to butyrate; And (c) at least one gene selected from the group consisting of genes encoding butyrate kinase, and amplifying aldehyde / alcohol dehydrogenase (aldehyde / alcohol dehydrogenase). It is characterized by.
- the enzyme that converts acetate and butyrate to acetyl CoA and butyryl CoA, and converts acetoacetylCoA to acetoacetate is CoA transferase.
- the gene encoding CoA transferase is ctfAB or atoDA .
- the gene encoding phosphotrans-butyrylase that converts the butyryl-CoA to butyrate is ptb.
- the gene encoding the butyrate kinase is characterized in that at least one gene selected from the group consisting of buk and buk II .
- the gene encoding the aldehyde / alcohol dehydrogenase is adhE1 or adhE2 and includes variants thereof.
- the variant is more preferably one or more of the 450 to 650th amino acid of the protein encoded by adhE1 (SEQ ID NO: 51).
- a gene encoding a enzyme for converting butyryl CoA to butyrate in a recombinant microorganism that has deleted a gene encoding phosphotransacetylase ( eutD ) ( buk or / and bukII ) to prepare a recombinant microorganism additionally deleted, and further deletes ctfA or ctfB encoding a CoA transferase (CoA transferase) to produce a recombinant microorganism, alcohol / aldehyde dehydro Recombinant microorganisms were further prepared by introducing genes encoding genease ( adhE1 ) and confirmed that these microorganisms had improved butanol production and reduced acetone production.
- adhE1 phosphotransacetylase
- a gene encoding butyryl coA and an enzyme that converts acetyl CoA to acetate After deletion of a gene encoding an enzyme that converts CoA) to butyrate, 1) alcoholol dehydrogenase; 2) aldehyde dehydrogenase; And 3) a method for producing a recombinant microorganism having increased butanol producing ability, characterized by further introducing or amplifying one or more genes selected from the group consisting of genes encoding alcohol / aldehyde dehydrogenase, It relates to a recombinant microorganism with increased butanol production capacity.
- the gene encoding the enzyme for converting the butyryl CoA (butyryl CoA) to butyrate may be a gene encoding phosphotrans-butyrylase ( ptb ) or a gene encoding a butyrate kinase ( buk, bukII ) Can be.
- the present invention also relates to the deletion of a gene encoding an enzyme that converts acetyl CoA to acetate in a host microorganism having an acetyl CoA and butyryl CoA biosynthetic pathway. And further deleting a gene encoding an enzyme for converting butyryl CoA to butyrate, and further deleting a gene encoding CoA transferase, and removing alcohol / aldehyde dehydrogenase.
- the present invention relates to a method for producing a recombinant microorganism having increased butanol producing ability, characterized by amplifying a gene for encoding, and a recombinant microorganism having increased butanol producing ability prepared therefrom.
- the gene encoding the alcoholol dehydrogenase is adh
- the gene encoding the aldehyde dehydrogenase is ald
- the gene encoding the alcohol / aldehyde dehydrogenase may be adhE1 .
- the adhE1 may increase butanol generating ability by amplifying in various forms.
- the various forms include the use of a circular promoter (pmoter) to control the expression time and expression amount, such as the ptb promoter or buk promoter thl promoter, including the mutation adhE1 .
- the present invention provides a gene encoding epoD- or pta or an acetate kinase, which encodes a phosphotrans-acetylase in a Clostridium spp.
- the present invention relates to a recombinant microorganism having increased butanol producing ability, which is characterized by the deletion of askA or ackA ).
- Clostridium acetobutylicum ⁇ eutD may be exemplified.
- the present invention provides a gene encoding epoD- or pta or an acetate kinase, which encodes a phosphotrans-acetylase in a Clostridium spp. askA or ackA ) is deleted, 1) a gene encoding butyrate transacetylase ( ptb ) or a gene encoding butyrate kinase ( buk or / and bukII ); 2)
- the present invention relates to a recombinant microorganism having increased butanol producing ability, characterized in that a gene selected from the group consisting of a gene encoding CoA transferase (CoA transferase) ( ctfAB or atoDA ) is further deleted.
- Clostridium acetonitrile unit Tilly glutamicum ATCC 824 ⁇ eutD ⁇ buk ⁇ bukII (Clostridium acetobutylicum ATCC 824 ⁇ eutD ⁇ buk)
- Clostridium acetonitrile unit Tilly glutamicum ATCC 824 ⁇ eutD ⁇ buk ⁇ ctfB (Clostridium acetobutylicum ATCC 824 ⁇ eutD ⁇ buk ⁇ ctfB ) can be illustrated.
- the present invention provides a gene encoding epoD- or pta or an acetate kinase, which encodes a phosphotrans-acetylase in a Clostridium spp. askA or ackA ) is deleted, 1) a gene encoding butyrate transacetylase ( ptb ) or a gene encoding butyrate kinase ( buk or / and bukII ); 2) a gene selected from the group consisting of genes ( ctfAB or atoDA ) encoding coate transferase (CoA transferase) is further deleted, aldehyde / alcohol dehydrogenase (aldehyde / alcohol dehydrogenase) It relates to a recombinant microorganism having increased butanol generating ability, characterized in that for amplifying.
- Clostridium acetonitrile unit Tilly glutamicum ATCC 824 ⁇ eutD ⁇ buk ⁇ buk PptbAdh (Clostridium acetobutylicum ATCC 824 ⁇ eutD ⁇ buk PptbAdh)
- Clostridium acetonitrile unit Tilly glutamicum ATCC 824 ⁇ eutD ⁇ buk ⁇ bukII PthlAdh * (Clostridium acetobutylicum ATCC 824 ⁇ eutD ⁇ buk PthlAdh *)
- the present invention comprises the steps of culturing the recombinant microorganism to produce butanol; And it relates to a method for producing butanol comprising the step of recovering butanol from the culture.
- the culturing of the recombinant microorganism and the recovery of ethanol and butanol may be performed using a culture method commonly known in the conventional fermentation industry and a separation and purification method of ethanol / butanol.
- the recovery of the butanol and ethanol is generally carried out after the completion of the culture, but in order to increase the productivity using a gas-stripping method (Thaddeus et al., Bioprocess Biosyst. Eng., 27: 207, 2005)
- Ethanol and butanol may be recovered during the culture. That is, it is also within the scope of the present invention to continue culturing while recovering ethanol and butanol produced during the cultivation.
- Example 1 Construction of a vector comprising a mutant loxP site and an antibiotic resistance label
- erythromycin resistance gene (EmR) is mainly used as an antibiotic resistance marker of the vector.
- EmR erythromycin resistance gene
- pSOS95-Cm which expresses chloramphenicol / thiamphenicol resistance label (hereinafter Thr) was used as a template for PCR using the thiolase promoter of Clostridium acetobutylicum.
- Thr chloramphenicol / thiamphenicol resistance label
- pSOS95-Cm can be produced by cloning the thioloase promoter of ATCC 824 strain to pSOS95 (Nair and Papoutsakis, J. Bacteriol., 176: 5843-5846, 1994) and cloning the chloramphenicol / thiamphenicol resistance gene in its downstream. .
- the inserted antibiotic resistance label must be removed for deletion of another gene.
- a mutant loxP sequence was added to a primer used to amplify Thr by PCR.
- the sequences GCATGC and TCTAGA of the restriction enzymes SphI and XbaI were added to the primers, respectively, to conjugate to the vector.
- the final primer sequence is shown in SEQ ID NOs: 1, 2.
- PCR amplification was performed using the template and the primer to obtain a product including both a mutant loxP site and Th r .
- the PCR product and the pUC18 plasmid thus obtained were cleaved with SphI / XbaI , and then conjugated to complete the vector pMBKOT2.
- pMBKOT2 is used to construct KO cassettes containing the loxP-Thr-loxP portion and homologous arm of pMBKOT2.
- gene deletion using homologous recombination uses plasmids that are not replicated in cells, but Clostridium acetobutylicum has a lower rate of transformation than E. coli and less homologous recombination. It is known that a replicable plasmid is used. Therefore, using the shuttle vector pIMP1 (Nair and Papoutsakis, J. Bacteriol. , 176: 5843-5846, 1994) that can be cloned from pMBKOT2 and Clostridium acetobutylicum prepared in Example 1, it is possible to delete specific genes. Vectors were produced.
- restriction enzyme sequences in pIMP1 are not suitable because they cut the inside of loxP-Th r -loxP sequences of pMBKOT2 except Xma I. Therefore, the sequence of NcoI, a restriction enzyme sequence not present in both pMBKOT2 and pIMP1, was added to pIMP1. About 300 base pairs (1155..1468 of L08752.1) located at pUC18 (GenBank ID: L08752.1) were used as templates, and PCR amplification was performed using the following SEQ ID NOs: 3 and 4 as primers. The NcoI base sequence was included in the primer of SEQ ID NO.
- the obtained PCR product was digested with pIMP1 with Nco I / Xma I and conjugated to prepare a pCACKO vector, and a gene deletion vector was prepared based on this vector.
- the desired gene (eutD or ctfB or buk or bukII) was amplified and conjugated with a thiamphenicol marker to the pCACKO vector prepared in Example 2, and then subjected to methylation, followed by C. actobutylicum ATCC 824 strain. Were transformed by electroporation (Mermelstein and Papoutsakis, Appl. Environ. Microbiol., 59 (4): 1077-1081, 1993).
- Transformed strains were passaged in 2x YTGS medium (16 g / L Bacto Tryptone, 10 g / L Bacto Yeast Extract, 4 g / L NaCl, 2 g / L Glucose, 15 g / L Soluble starch, pH 6.8) Plated in 2x YTG agar (16 g / L Bacto Tryptone, 10 g / L Bacto Yeast Extract, 4 g / L NaCl, 5 g / L Glucose, 15 g / L Agar, pH 5.8) containing thiophenicol .
- a vector expressing Cre recombinase was prepared in order to remove the thiophenicol resistance gene, which is an antibiotic resistance marker inserted into the gene after deletion of a specific gene through Experimental Example 1.
- pSOS95 GenBank ID: AY187686.1
- a promoter of thiolase gene of C. acetobutylicum was used as a parent vector.
- acetobutylicum and the strands containing the ribosome binding site and the XbaI site are amplified using the primers of SEQ ID NOs: It was.
- the amplified product and pSOS95 were cleaved with BamHI / NarI, and then conjugated using T4 ligase to prepare pSOS95-X vector.
- pJW168 (Palmeros et al., Gene , 247: 255-264, 2000) was used as a template to amplify the cre gene, and amplified by PCR using the following SEQ ID NOs: 7 and 8 as primers.
- the amplified product and pSOS95-X were cleaved with XbaI / NarI , and then conjugated using T4 ligase to prepare pSOS95del-cre vector.
- PSOS95del-cre prepared in Experimental Example 2 was transformed by electroporation to the C. actobutylicum ATCC 824 recombinant strain in which the target gene was deleted in the same manner as in Experimental Example 1.
- the transformed strain was passaged 3 to 5 times in 2x YTGS medium, and then plated in 2x YTG agar. When colony grows, it is replicated to 2x YTG agar containing Th to identify colony that lost Th r, and then Th r marker is displayed due to the difference in the length of gene amplified by colony PCR using primers inside and outside the deleted gene. Confirm that it was removed.
- the selected colony was selected as a colony in which pSOL1 was not lost through the degeneration test as in Experimental Example 1.
- the colony finally confirmed was selected as the colony in which pSOL1 was not lost and pSOS95del-Cre was lost through passage in the same manner as in Experimental Example 1. Since the strain obtained by the above method does not have any antibiotic resistance markers, the existing vector can be used without altering the markers in the subsequent deletion of other genes.
- each strand containing the ORF of eutD using primers SEQ ID NOs: 9 and 10, SEQ ID NOs: 11 and 12, respectively (NCBI RefSeq ID: 1890304 of NC_003030.1. 1890770, 1890831..1891380) were amplified by PCR.
- the template was selected so that the sequence to be amplified does not have Nco I and Xma I sequences. It was found that the two parts of the ORF contained in each amplified product did not overlap each other and matched in directionality.
- a portion of pMBKOT2 including loxP-Th r -loxP was amplified using primers of SEQ ID NOs: 13 and 14 to insert a label between the two strands.
- the final product thus prepared was cleaved with NcoI / XmaI with the KO vector pCACKO prepared in Example 2 and conjugated to prepare a pCACKO-eutD vector, which was subjected to methylation and electroporated to the strain C. actobutylicum ATCC 824. Transformation.
- the transformed strain was plated on 2x YTG agar containing thiamphenicol while subcultured in 2x YTGS medium. Colony obtained from the plate was confirmed by the successful insertion of the Th r marker in the eutD ORF by colony PCR with SEQ ID NO: 15 and 16, 17 and 18, respectively.
- SEQ ID NO: 16 5'-TTGCCGTCCTAAACTCTGAA-3 '
- pSOS95del-cre was transformed into the final selected strain in the same manner as in Experimental Example 3 to remove the cyamphenicol resistance gene inserted into the gene, and pSOS95del-cre was removed through passage to remove cyamphenicol and
- the final strain Clostridium acetobutylicum ATCC 824 ⁇ eutD ), which is sensitive to an antibiotic such as erythromycin and wild-type strain and lacks the eutD gene, was prepared.
- Clostridium acetobutylicum ATCC 824 ⁇ eutD strain in order to delete one or more genes selected from buk, bukII, ctfB , Clostridium acetobutylicum ATCC 824 ⁇ eutD as a host microorganism in the same manner as in Example 3 Further deletion made recombinant microorganisms. And it was introduced into the alcohol / aldehyde dehydrogenase gene of a gene adhE1 of C. acetobutylicum ATCC 824 expressing the corresponding strain.
- SEQ ID NOs: 19 to 36 were used.
- SEQ ID NOS: 19-24 we used the SEQ ID NO: 25 and 30 in order to bukII gene deletion was used to SEQ ID NO: 31 ⁇ 36 to the ctfB gene deletions, respectively.
- the adhE1 gene of C. acetobutylicum ATCC 824 was amplified by PCR using primers SEQ ID NO: 37 and 38. PCR products were cloned between the promoter of the ptb gene of the pIMP1exter vector and the ctfB transcription terminator. The PCR product and the pIMP1exter vector were respectively digested with SalI / EcoRI restriction enzymes and conjugated. The pIMP1exter vector was cloned into the PstI and SalI restriction sites of the pIMP1 (Nair and Papoutsakis, J. Bacteriol.
- pTHL-Adh * is a pTHL1-Cm vector and the fragment amplified using SEQ ID NO: 43 and SEQ ID NO: 44 and the fragment amplified by SEQ ID NO: 45 and SEQ ID NO 46 by overlap PCR, and then placed in the PstI and AvaI restriction enzyme site It was produced by cloning.
- the mutant Adh * is a protein produced by cloning the adhE1 fragment amplified by SEQ ID NO: 43 and SEQ ID NO: 46 in the pTHL1-Cm vector, and artificially recombinant from the results of mutation screening using NTG.
- Adh * used in this example is reproduced artificially using SEQ ID NOs: 43-46 at the position where the frequency of change is highest in these libraries.
- Clostridium acetonitrile unit Tilly glutamicum ATCC 824 ⁇ eutD ⁇ buk ⁇ bukII (Clostridium acetobutylicum ATCC 824 ⁇ eutD ⁇ buk)
- Clostridium acetonitrile unit Tilly glutamicum ATCC 824 ⁇ eutD ⁇ buk ⁇ ctfB (Clostridium acetobutylicum ATCC 824 ⁇ eutD ⁇ buk ⁇ ctfB)
- Clostridium acetonitrile unit Tilicum ATCC 824 ⁇ eutD ⁇ buk ⁇ buk PptbAdh ( Clostridium acetobutylicum ATCC 824 ⁇ eutD ⁇ buk PptbAdh)
- the method of preparing the pTHL1-Cm vector is as follows.
- a shuttle vector for exogenous protein expression comprising a thiolase promoter and a ribosomal binding site (RBS) of Clostridium acetobutylicum was prepared as follows.
- Thiolase is known to be able to express genes continuously and stably without being strongly influenced by the cell growth cycle (Tummala et al., Appl. Environ. Microbiol., 65: 3793-3799, 1999). Therefore, in this example, the promoter located on the top of the thiolase (NCBI GeneID: 1119056) was cloned and inserted into pIMP-H1del.
- pIMP-H1del is a shuttle vector that uses pIMP1 as a template by removing one HindIII site in the 3408th base from the pIMP1 having two HindIII restriction sites and leaving only the restriction site located in the 743th base sequence.
- the primers of SEQ ID NO: 47, SEQ ID NO: 48, and total DNA of Clostridium acetobutylicum (ATCC 824) strain were PCR-templated to amplify the thiolase promoter. After amplified thiolase promoter fragments were purified and recovered, treated with HindIII and PstI restriction enzymes, and then conjugated with the same enzyme-treated pIMP-H1del shuttle vector to complete pTHL1 vector production.
- PCR of the primers of SEQ ID NO: 49 and SEQ ID NO: 50, pSOS95-Cm was used to amplify the chloramphenicol resistance genes, and after purification and recovery of the amplified chloramphenicol resistance gene fragments, treatment with HindIII restriction enzymes was performed.
- PTHL1-Cm vector construction was completed by ligation with the enzyme-treated pTHL1 shuttle vector.
- pSOS95-Cm can be produced by cloning the thioloase promoter of ATCC 824 strain to pSOS95 (Nair and Papoutsakis, J. Bacteriol., 176: 5843-5846, 1994) and cloning the chloramphenicol / thiamphenicol resistance gene in its downstream. .
- the glucose in the medium was measured by a glucose analyzer (model 2700 STAT, Yellow Springs Instrument, Yellow Springs, Ohio, USA), and the medium was collected over time, and the acetone, ethanol and butanol concentrations produced therefrom were packed column (Supelco a Carbopack TM BAW / 6.6% PEG20M, 2m ⁇ 2 mm ID, Bellefonte, PA, USA) is Agillent 6890N GC System, Agilent Technologies (equipped with gas chromatography) to measure the organic solvent, the yield shown in Table 2 and Table 3 .
- the recombinant microorganism Clostridium acetobutylicum ATCC824 ⁇ eutD prepared in Example 3 was produced in terms of butanol concentration and butanol yield in comparison to that in the control wild-type Clostridium acetobutylicum ATCC 824 produced less than 10 g / L butanol. It was confirmed that the production capacity was improved. In addition, it was confirmed that the production yield as well as the final production concentration of ethanol and butanol were improved.
- the recombinant strain C. actobutylicum ATCC 824 ⁇ eutD ⁇ buk strain can be seen that in terms of yield (yield) similar to the C. actobutylicum ATCC 824 ⁇ eutD deletion strain. This is because acetic acid and butyrate are still produced when the gene in the butyrate production pathway and the gene in the acetic acid pathway are deleted simultaneously. In the present invention, it was possible to develop the excellent butanol-producing strains shown above.
- the present invention was able to complete the present invention by revealing a new fact using eutD, buk (or / and bukII ), ctfB deletion strain of the present invention that acetic acid production can also be produced by the role of coate transferase. Most of the strains shown above are characterized by little butyrate and acetic acid at the end of fermentation.
- the present invention has the effect of providing a recombinant microorganism having a high production capacity of butanol selectively through the deletion or inactivation of specific genes.
- Recombinant microorganism according to the present invention is useful for the industrial production of butanol, as well as the production of organic acids such as acetate, butyrate, and by-products such as acetone by metabolic flow manipulation, and can improve the hourly productivity of butanol.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims (28)
- 아세틸코에이(acetyl CoA) 및 부티릴코에이(butyryl CoA) 생합성 경로를 가지고 있는 숙주 미생물에서, 아세틸코에이(acetyl CoA)를 아세테이트로 전환하는 효소를 코딩하는 유전자를 결실시키는 것을 특징으로 하는 부탄올 생성능이 증가된 재조합 미생물의 제조방법.
- 제1항에 있어서, (a) 아세테이트 및 부티레이트를 각각 아세틸코에이(acetyl CoA) 및 부티릴코에이(butyryl CoA)로 전환하고, 아세토아세틸코에이(acetoacetylCoA)를 아세토아세테이트로 전환하는 효소를 코딩하는 유전자; 및 (b) 부티릴코에이(butyryl-CoA)를 부티레이트로 전환하는 효소를 코딩하는 유전자로 구성된 군에서 선택되는 유전자를 추가로 결실시키는 것을 특징으로 하는 방법.
- 제1항 또는 제2항에 있어서, 1) 알콜올 디하이드로게나제; 2) 알데히드 디하이드로게나제; 및 3) 알코올/알데히드 디하이드로게나제를 코딩하는 유전자로 구성된 군에서 선택되는 유전자를 1개 이상 추가로 증폭시키는 것을 특징으로 하는 방법.
- 제3항에 있어서, 상기 알콜올 디하이드로게나제를 코딩하는 유전자는 adh이고, 상기 알데히드 디하이드로게나제를 코딩하는 유전자는 ald이며, 상기 알코올/알데히드 디하이드로게나제를 코딩하는 유전자는 adhE1인 것을 특징으로 하는 방법.
- 제 3항에 있어서, 상기 알코올/알데히드 디하이드로게나제 (alcohol/aldehyd dehydrogeanse)는 서열번호 51의 아미노산 서열 또는 상기 서열중 450번째부터 650번째 아미노산 사이에 1개 이상의 변이가 있는 것임을 특징으로 하는 방법.
- 제1항에 있어서, 상기 숙주 미생물은 클로스트리듐(Clostridium) 속 유래인 것을 특징으로 하는 방법.
- 제1항에 있어서, 상기 아세틸코에이(acetyl CoA)를 아세테이트로 전환하는 효소는 포스포트랜스-아세틸라제(phosphotrans-acetylase) 또는 아세테이트 키나제(acetate kinase)인 것을 특징으로 하는 방법.
- 제7항에 있어서, 상기 포스포트랜스-아세틸라제(phosphotrans-acetylase)를 코딩하는 유전자는 eutD 또는 pta이고, 상기 아세테이트 키나제(acetate kinase)를 코딩하는 유전자는 askA 또는 ackA인 것을 특징으로 하는 방법.
- 제2항에 있어서, 상기 아세테이트 및 부티레이트를 각각 아세틸코에이(acetyl CoA) 및 부티릴코에이(butyryl CoA)로 전환하고, 아세토아세틸코에이(acetoacetylCoA)를 아세토아세테이트로 전환하는 효소는 코에이트랜스퍼라제(CoA transferase)이고, 부티릴코에이(butyryl-CoA)를 부티레이트로 전환하는 효소는 포스포트랜스-부티릴라제(phosphotrans-butyrylase) 또는 부티레이트 키나제(butyrate kinase)인 것을 특징으로 하는 방법.
- 제9항에 있어서, 상기 코에이트랜스퍼라제(CoA transferase)를 코딩하는 유전자는 ctfAB 또는 atoDA인 것을 특징으로 하고, 상기 포스포트랜스-부티릴라제(phosphotrans-butyrylase)를 코딩하는 유전자는 ptb이고, 상기 부티레이트 키나제(butyrate kinase)를 코딩하는 유전자는 buk 및 bukII로 구성된 군에서 선택되는 1종 이상의 유전자인 것을 특징으로 하는 방법.
- 아세틸코에이(acetyl CoA) 및 부티릴코에이(butyryl CoA)로의 생합성 경로를 가지는 숙주 미생물에서, 아세틸코에이(acetyl CoA)를 아세테이트로 전환하는 효소를 코딩하는 유전자가 결실되어 있는 것을 특징으로 하는 부탄올 생성능이 증가된 재조합 미생물.
- 제11항에 있어서, (a) 아세테이트 및 부티레이트를 각각 아세틸코에이(acetyl CoA) 및 부티릴코에이(butyryl CoA)로 전환하고, 아세토아세틸코에이(acetoacetylCoA)를 아세토아세테이트로 전환하는 효소를 코딩하는 유전자; 및 (b) 부티릴코에이(butyryl-CoA)를 부티레이트로 전환하는 효소를 코딩하는 유전자로 구성된 군에서 선택되는 유전자가 추가로 결실되어 있는 것을 특징으로 하는 재조합 미생물.
- 제11항 또는 제12항에 있어서, 1) 알콜올 디하이드로게나제; 2) 알데히드 디하이드로게나제; 및 3) 알코올/알데히드 디하이드로게나제를 코딩하는 유전자로 구성된 군에서 선택되는 유전자가 1개 이상 추가로 증폭되어 있는 것을 특징으로 하는 재조합 미생물.
- 제13항에 있어서, 상기 알콜올 디하이드로게나제를 코딩하는 유전자는 adh이고, 상기 알데히드 디하이드로게나제를 코딩하는 유전자는 ald이며, 상기 알코올/알데히드 디하이드로게나제를 코딩하는 유전자는 adhE1인 것을 특징으로 하는 재조합 미생물.
- 제13항 또는 14항에 있어서, 상기 알코올/알데히드 디하이드로게나제 (alcohol/aldehyd dehydrogeanse)는 서열번호 51의 아미노산 서열 또는 상기 서열중 450번째부터 650번째 아미노산 사이에 1개 이상의 변이가 있는 것임을 특징으로 하는 재조합 미생물.
- 제11항에 있어서, 상기 숙주 미생물은 클로스트리듐(Clostridium) 속 유래인 것을 특징으로 하는 재조합 미생물.
- 제11항에 있어서, 상기 아세틸코에이(acetyl CoA)를 아세테이트로 전환하는 효소는 포스포트랜스-아세틸라제(phosphotrans-acetylase) 또는 아세테이트 키나제(acetate kinase)인 것을 특징으로 하는 재조합 미생물.
- 제17항에 있어서, 상기 포스포트랜스-아세틸라제(phosphotrans-acetylase)를 코딩하는 유전자는 eutD 또는 pta이고, 상기 아세테이트 키나제(acetate kinase)를 코딩하는 유전자는 askA 또는 ackA인 것을 특징으로 하는 재조합 미생물.
- 제12항에 있어서, 상기 아세테이트 및 부티레이트를 각각 아세틸코에이(acetyl CoA) 및 부티릴코에이(butyryl CoA)로 전환하고, 아세토아세틸코에이(acetoacetylCoA)를 아세토아세테이트로 전환하는 효소는 코에이트랜스퍼라제(CoA transferase)이고, 부티릴코에이(butyryl-CoA)를 부티레이트로 전환하는 효소는 포스포트랜스-부티릴라제(phosphotrans-butyrylase) 또는 부티레이트 키나제(butyrate kinase)인 것을 특징으로 하는 재조합 미생물.
- 제19항에 있어서, 상기 코에이트랜스퍼라제(CoA transferase)를 코딩하는 유전자는 ctfAB 또는 atoDA인 것을 특징으로 하고, 상기 포스포트랜스-부티릴라제(phosphotrans-butyrylase)를 코딩하는 유전자는 ptb이고, 상기 부티레이트 키나제(butyrate kinase)를 코딩하는 유전자는 buk 및 bukII로 구성된 군에서 선택되는 1종 이상의 유전자인 것을 특징으로 하는 재조합 미생물.
- 클로스트리듐(Clostridium) 속 미생물에서, 포스포트랜스-아세틸라제(phosphotrans-acetylase)를 코딩하는 유전자(eutD 또는 pta) 또는 아세테이트 키나제(acetate kinase)를 코딩하는 유전자(askA 또는 ackA)가 결실되어 있는 것을 특징으로 하는 부탄올 생성능이 증가된 재조합 미생물.
- 제21항에 있어서, 상기 부탄올 생성능이 증가된 재조합 미생물은 클로스트리듐 아세토부틸리쿰 ATCC 824 ΔeutD (Clostridium acetobutylicum ΔeutD)인 것을 특징으로 하는 재조합 미생물.
- 부탄올 생성능이 증가된 재조합 미생물 Clostridium acetobutylicum ATCC 824 ΔeutD Δbuk PptbAdh.
- 부탄올 생성능이 증가된 재조합 미생물 Clostridium acetobutylicum ATCC 824 ΔeutD Δbuk PthlAdh*.
- 부탄올 생성능이 증가된 재조합 미생물 C. actobutylicum ATCC 824 ΔeutD Δbuk ΔbukII PthlAdh*.
- 부탄올 생성능이 증가된 재조합 미생물 C. actobutylicum ATCC 824 ΔeutD Δbuk ΔbukII ΔctfB PthlAdh*.
- 제11항, 제 12항 및 제16항∼제26항중 어느 한 항의 재조합 미생물을 배양하여 부탄올을 생성하는 단계; 및 상기 배양액으로부터 부탄올을 회수하는 단계를 포함하는 부탄올의 제조방법.
- 제 13항의 재조합 미생물을 배양하여 부탄올을 생성하는 단계; 및 상기 배양액으로부터 부탄올을 회수하는 단계를 포함하는 부탄올의 제조방법.
Priority Applications (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13/497,743 US9096872B2 (en) | 2009-09-22 | 2010-09-21 | Recombinant microorganisms having increased ability to produce butanol and method of producing butanol using the same |
CN201080052858.2A CN102666839B (zh) | 2009-09-22 | 2010-09-21 | 具有提高的生产丁醇能力的重组微生物和使用其生产丁醇的方法 |
EP10819056.2A EP2481793B8 (en) | 2009-09-22 | 2010-09-21 | Recombinant microorganism with increased butanol production ability, and preparation method of butanol using same |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20090089829 | 2009-09-22 | ||
KR10-2009-0089829 | 2009-09-22 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2011037415A2 true WO2011037415A2 (ko) | 2011-03-31 |
WO2011037415A3 WO2011037415A3 (ko) | 2011-11-03 |
Family
ID=43796392
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2010/006511 WO2011037415A2 (ko) | 2009-09-22 | 2010-09-21 | 부탄올 생성능이 증가된 재조합 미생물 및 이를 이용한 부탄올의 제조방법 |
Country Status (5)
Country | Link |
---|---|
US (1) | US9096872B2 (ko) |
EP (1) | EP2481793B8 (ko) |
KR (1) | KR101277711B1 (ko) |
CN (1) | CN102666839B (ko) |
WO (1) | WO2011037415A2 (ko) |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9567613B2 (en) | 2012-07-30 | 2017-02-14 | Gs Caltex Corporation | Recombinant microorganism having enhanced butanol producing ability and method for producing butanol using the same |
US9957529B2 (en) | 2012-11-20 | 2018-05-01 | Gs Caltex Corporation | Recombinant microorganism with improved butanol production ability and method for producing butanol by using the same |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP6236209B2 (ja) * | 2013-03-26 | 2017-11-22 | 株式会社日本触媒 | ブタノールの製造方法 |
CN103279689B (zh) * | 2013-05-20 | 2016-08-17 | 天津大学 | 基于fk506生产菌筑波链霉菌基因组尺度代谢网络模型指导下次级途径改造方法 |
TWI512105B (zh) * | 2014-01-17 | 2015-12-11 | Univ Feng Chia | 可生產丁酸的菌株、可生產正丁醇的菌株、及自丁酸生成正丁醇的方法 |
KR101548480B1 (ko) | 2015-02-11 | 2015-08-31 | 지에스칼텍스 주식회사 | 혼합당 동시발효능을 갖는 미생물 및 이를 이용한 부탄올의 생산 방법 |
US11692207B2 (en) | 2016-05-05 | 2023-07-04 | Newpek S.A. De C.V. | Enzymatic methods for butanol production |
JP7126403B2 (ja) * | 2018-08-06 | 2022-08-26 | 株式会社日本触媒 | 遺伝子改変クロストリジウム・サッカロパーブチルアセトニカム種微生物 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008052973A2 (en) | 2006-10-31 | 2008-05-08 | Metabolic Explorer | Process for the biological production of n-butanol with high yield |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090155869A1 (en) * | 2006-12-01 | 2009-06-18 | Gevo, Inc. | Engineered microorganisms for producing n-butanol and related methods |
CN101519673B (zh) * | 2008-02-27 | 2013-02-06 | 中国科学院上海生命科学研究院 | 一种提高梭菌产丁醇比例的方法 |
EP2267141A1 (en) * | 2009-06-26 | 2010-12-29 | Metabolic Explorer | Process for the biological production of n-Butanol with high yield |
-
2010
- 2010-09-20 KR KR1020100092733A patent/KR101277711B1/ko active Active
- 2010-09-21 EP EP10819056.2A patent/EP2481793B8/en active Active
- 2010-09-21 CN CN201080052858.2A patent/CN102666839B/zh active Active
- 2010-09-21 WO PCT/KR2010/006511 patent/WO2011037415A2/ko active Application Filing
- 2010-09-21 US US13/497,743 patent/US9096872B2/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008052973A2 (en) | 2006-10-31 | 2008-05-08 | Metabolic Explorer | Process for the biological production of n-butanol with high yield |
Non-Patent Citations (13)
Title |
---|
CLARK, S.W. ET AL., APPL. ENVIRON. MICROBIOL., vol. 55, 1989, pages 970 |
GREEN ET AL., MICROBIOLOGY, vol. 142, 1996, pages 2079 - 2086 |
JIANG ET AL., METAB. ENG., vol. 11, no. 4-5, 2009, pages 284 - 291 |
LEE ET AL., BIOTECHNOL. BIOENG., vol. 101, no. 2, 2008, pages 209 - 228 |
MERMELSTEIN; PAPOUTSAKIS, APPL. ENVIRON. MICROBIOL., vol. 59, no. 4, 1993, pages 1077 - 1081 |
NAIR; PAPOUTSAKIS, J. BACTERIOL., vol. 176, 1994, pages 5843 - 5846 |
NOLLING ET AL., J. BACTERIOL., 2001 |
PALMEROS ET AL., GENE, vol. 247, 2000, pages 255 - 264 |
SCOTCHER; BENNETT, J. BACTERIOL., vol. 187, no. 6, 2005, pages 1930 - 1936 |
See also references of EP2481793A4 |
STIM-HERNDON, K.P. ET AL., BIOTECHNOL./FOOD MICROBIOL., vol. 2, 1996, pages 11 |
THADDEUS ET AL., BIOPROCESS BIOSYST. ENG, vol. 27, 2005, pages 207 |
TUMMALA ET AL., APPL. ENVIRON. MICROBIOL., vol. 65, 1999, pages 3793 - 3799 |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9567613B2 (en) | 2012-07-30 | 2017-02-14 | Gs Caltex Corporation | Recombinant microorganism having enhanced butanol producing ability and method for producing butanol using the same |
US9957529B2 (en) | 2012-11-20 | 2018-05-01 | Gs Caltex Corporation | Recombinant microorganism with improved butanol production ability and method for producing butanol by using the same |
Also Published As
Publication number | Publication date |
---|---|
EP2481793A4 (en) | 2013-07-10 |
US20130017588A1 (en) | 2013-01-17 |
KR20110033089A (ko) | 2011-03-30 |
US9096872B2 (en) | 2015-08-04 |
EP2481793A2 (en) | 2012-08-01 |
CN102666839B (zh) | 2015-08-19 |
WO2011037415A3 (ko) | 2011-11-03 |
EP2481793B1 (en) | 2017-08-30 |
KR101277711B1 (ko) | 2013-06-24 |
CN102666839A (zh) | 2012-09-12 |
EP2481793B8 (en) | 2017-11-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2011037415A2 (ko) | 부탄올 생성능이 증가된 재조합 미생물 및 이를 이용한 부탄올의 제조방법 | |
WO2019203435A1 (ko) | 유기산 내성 효모 유래 신규 프로모터 및 이를 이용한 목적유전자의 발현방법 | |
KR101444968B1 (ko) | 높은 수율로 n-부탄올을 생물학적으로 생산하는 방법 | |
WO2019117673A2 (ko) | 신규 폴리펩타이드 및 이를 이용한 imp 생산방법 | |
WO2019117671A1 (ko) | 5'-이노신산을 생산하는 미생물 및 이를 이용한 5'-이노신산의 생산 방법 | |
WO2011037414A2 (ko) | 알코올 생성능이 증가된 재조합 변이 미생물 및 이를 이용한 알코올의 제조방법 | |
WO2015194921A1 (ko) | 신규한 피키아 쿠드리압즈비 ng7 균주 및 이의 용도 | |
WO2016032279A9 (en) | Recombinant Yeast Producing 3-Hydroxypropionic Acid and Method for Producing 3-Hydroxypropionic Acid Using the Same | |
WO2019203436A1 (ko) | 에탄올 생산 경로가 억제된 내산성 효모 및 이를 이용한 젖산의 제조방법 | |
WO2011155799A2 (ko) | 탄화수소 생성능을 가지는 변이 미생물 및 이를 이용한 탄화수소의 제조방법 | |
WO2020075986A2 (ko) | 알코올 생성이 억제된 재조합 내산성 효모 및 이를 이용한 젖산의 제조방법 | |
WO2009082148A2 (en) | Enhanced ethanol and butanol producing microorganisms and method for preparing ethanol and butanol using the same | |
WO2015163682A1 (ko) | 2,3-부탄디올의 생성능이 증강된 재조합 미생물 및 이를 이용한 2,3-부탄디올의 생산 방법 | |
WO2015093831A1 (ko) | D(-)2,3-부탄디올의 생성능이 증강된 재조합 미생물 및 이를 이용한 d(-)2,3-부탄디올의 생산 방법 | |
Hönicke et al. | Chemostat cultivation and transcriptional analyses of Clostridium acetobutylicum mutants with defects in the acid and acetone biosynthetic pathways | |
WO2014148754A1 (ko) | 2,3-부탄디올의 생성능이 증강된 재조합 미생물 및 이를 이용한 2,3-부탄디올의 생산 방법 | |
WO2012046924A1 (ko) | 아라비노스 대사경로가 도입된 자일리톨 생산균주 및 이를 이용한 자일리톨 생산방법 | |
WO2013103246A2 (ko) | 퀴놀린산을 생산하는 재조합 미생물 및 이를 이용한 퀴놀린산의 생산 방법 | |
WO2018131898A2 (ko) | 메틸로모나스 속 dh-1 균주의 신규한 용도 | |
WO2020075943A1 (ko) | 고활성의 말산 탈수소효소가 도입된 숙신산 생성용 변이 미생물 및 이를 이용한 숙신산 제조방법 | |
WO2014081084A1 (ko) | 부탄올 생성능이 증강된 재조합 미생물 및 이를 이용한 부탄올 생산 방법 | |
WO2015060649A1 (ko) | O-숙시닐호모세린 생산 미생물 및 이를 이용한 o-숙시닐호모세린의 생산방법 | |
Monaghan et al. | Deletion of glyceraldehyde‐3‐phosphate dehydrogenase (gapN) in Clostridium saccharoperbutylacetonicum N1‐4 (HMT) using CLEAVE™ increases the ATP pool and accelerates solvent production | |
KR101284015B1 (ko) | 부탄올 또는 혼합알코올 생성능 및 아세톤 제거능이 증가된 재조합 변이 미생물 및 이를 이용한 부탄올 또는 혼합 알코올의 제조방법 | |
WO2020085879A1 (ko) | 아세틴 화합물의 생물학적 제조 방법 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080052858.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10819056 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
REEP | Request for entry into the european phase |
Ref document number: 2010819056 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010819056 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13497743 Country of ref document: US |